Moxidectin

(Moxidectin®)

Moxidectin

Drug updated on 11/17/2023

Dosage FormTablet (oral; 2 mg)
Drug ClassAntihelminthics
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Moxidectin is indicated for the treatment of onchocerciasis due to Onchocerca volvulus in patients aged 12 years and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Moxidectin (moxidectin) Prescribing Information.2021Medicines Development for Global Health, Melbourne, Victoria, Australia

Systematic Reviews / Meta-Analyses